Academic Rank:
Clinical Assistant Professor (UBC), Department of Pathology and Laboratory Medicine
Staff Hematopathologist, Fraser Health Authority
Affiliation(s):
Royal Columbian Hospital
Short Bio:

Dr. Razavi is a UBC trained hematopathologist working in Fraser Health Authority (Royal Columbian Hospital). His previous academic profile includes undertaking undergraduate and graduate degrees from University of Toronto and UWO where he obtained his PHD in pharmacology and critical care medicine. Prior to medical school at the University of Ottawa, he trained as a post doctoral fellow in physiology. Following medical school and briefly training in Anesthesiology he switched residency tracks to complete a hematopathology residency at the University of British Columbia. He is a board certified fellow of the Royal College of Physicians and Surgeons of Canada (RCPSC). His professional interests include all areas of benign and malignant hematology, transfusion medicine, coagulation disorders and hemoglobinopathy among others. He is actively involved in resident teaching and resident-lead research projects.

Academic background

  • Fellow, Royal College of Physicians of Canada (FRCPC), Hematological Pathology. 2017
  • Board-certified, Hematological Pathology, Royal College of Physicians and Surgeons of Canada (RCPSC). 2017
  • Licentiate of the Medical Council of Canada (LMCC). 2016
  • Doctor of Medicine, UOttawa. 2010
  • Post Doctoral Fellowship, Physiology and Translational medicine, Texas A&M. 2006
  • Doctor of Philosophy, Pharmacology, UWO. 2003.
  • Master of Science, Pharmacology and Toxicology, UofT. 1998.
  • Bachelor of Science, Pharmacology and Toxicology, UofT. 1995.

Publications: https://pubmed.ncbi.nlm.nih.gov/?term=habib+moshref+razavi

Selected Publications:

  • A case of bony lytic lesions in a patient with Gaucher disease. Clin Case Rep. 2019;00:1–4.
  • Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient. Blood 2019 133:381
  • Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol. 290(6):L1164-72
  • Pulmonary Oxidant Stress in Murine Sepsis is Due to Inflammatory Cell Inducible Nitric Oxide. Crit Care Med. 33(6):1333-9.
  • Modulation of Apoptosis by Nitric Oxide: Implications in Myocardial Ischemia and Heart Failure. Pharmacol Ther. 106(2):147-62.
  • Pulmonary Neutrophil Infiltration in Murine Sepsis: Role of Inducible Nitric Oxide synthase. Am J Respir Crit Care Med. 170(3):227-33.
  • Effects of nebulized diethylenetetraamine-NONOate in a mouse model of acute Pseudomonas aeruginosa pneumonia. Chest. 122(6):2127-36.
  • Role of inducible nitric oxide synthase in pulmonary microvascular protein leak in murine sepsis. Am J Respir Crit Care Med. 165(12):1634-9.
  • Effects of inhaled nitric oxide in a mouse model of sepsis-induced acute lung injury. Crit Care Med. 30(4):868-73.

Research Interest

Research interests include medical education and use of social media in pathology education.

Teaching Interest

Dr. Razavi is involved in teaching lab science and medical students, residents and fellows. The scope of his teaching includes areas of benign and malignant hematology, coagulation, transfusion medicine etc.